Laird Superfood Navigates Equity Growth Amidst Past Product Woes

TL;DR

Laird Superfood is burning cash and diluting shareholders, but their past product quality issues are finally settled, so maybe there's a glimmer of hope.

AI Summary

Laird Superfood, Inc. reported a net loss for the second quarter of 2025, with common stock outstanding increasing to 11,020,792 shares as of June 30, 2025, up from 10,644,461 shares at December 31, 2024. The company's additional paid-in capital also saw an increase, reaching $10,668,705 by June 30, 2025, compared to $10,292,374 at December 31, 2024. This increase in shares and capital suggests ongoing equity financing activities. A significant operational change involved a product quality issue identified in January 2023 with raw material from one vendor, leading to a voluntary product withdrawal and associated costs for testing, discounts, and inventory obsolescence. However, the company reached a settlement with the supplier in Q3 2023 and recorded recoveries in 2024, mitigating some of these prior losses. The company continues to manage significant net operating loss carryforwards, with some beginning to expire in 2025 and others extending indefinitely or for 15-20 years until 2031 or 2036, indicating a long-term strategy to offset future taxable income. The filing also noted 8,772 shares of common stock withheld to cover stock option exercise costs in Q2 2025, and 86,643 shares withheld for the same purpose in Q1 2025, alongside 287,148 shares withheld for taxes in 2024, reflecting ongoing employee equity compensation management.

Why It Matters

For investors, the increase in common stock outstanding to 11,020,792 shares and additional paid-in capital to $10,668,705 indicates ongoing dilution but also successful capital raises, crucial for funding operations in a competitive superfood market. Employees holding stock options are directly impacted by the 8,772 shares withheld for exercise costs, reflecting the value and cost of their equity compensation. Customers benefit from the company's proactive handling of the January 2023 product quality issue and subsequent settlement, demonstrating a commitment to product integrity and potentially rebuilding trust. The broader market for health and wellness products sees Laird Superfood's continued efforts to manage past challenges and secure financing, highlighting the capital-intensive nature of scaling in this sector against competitors like Vital Proteins and Garden of Life.

Risk Assessment

Risk Level: medium — The company's continued reliance on equity financing, evidenced by the increase in common stock outstanding to 11,020,792 shares and additional paid-in capital to $10,668,705, suggests ongoing cash burn and potential future dilution for existing shareholders. While the settlement of the 2023 product quality issue in 2024 is positive, the initial event and associated costs highlight operational risks in supply chain management.

Analyst Insight

Investors should closely monitor Laird Superfood's future revenue growth and profitability metrics to justify the ongoing share dilution. Evaluate the effectiveness of their capital deployment and watch for signs of sustainable positive cash flow before considering a long position.

Key Numbers

• $11,020,792 — Common Stock Outstanding (Increased from $10,644,461 at Dec 31, 2024, indicating dilution.)
• $10,668,705 — Additional Paid-In Capital (Increased from $10,292,374 at Dec 31, 2024, reflecting capital raises.)
• 8,772 shares — Shares Withheld (For stock option exercise costs in Q2 2025.)
• 287,148 shares — Shares Withheld (For taxes in 2024.)
• 2023 — Product Quality Issue (Identified in January 2023, settled in Q3 2023, recoveries in 2024.)

Key Players & Entities

• Laird Superfood, Inc. (company) — filer of the 10-Q
• $11,020,792 (dollar_amount) — common stock outstanding as of June 30, 2025
• $10,644,461 (dollar_amount) — common stock outstanding as of December 31, 2024
• $10,668,705 (dollar_amount) — additional paid-in capital as of June 30, 2025
• $10,292,374 (dollar_amount) — additional paid-in capital as of December 31, 2024
• January 2023 (date) — product quality issue identified
• Q3 2023 (date) — settlement reached with supplier
• 2024 (date) — recoveries recorded from supplier settlement
• 8,772 shares (dollar_amount) — common stock withheld for stock option exercise costs in Q2 2025
• 287,148 shares (dollar_amount) — common stock withheld to cover taxes in 2024

FAQ

Risk Factors

• Product Quality Issue and Withdrawal [medium — operational]: In January 2023, a product quality issue with raw material from a vendor led to a voluntary withdrawal of affected finished goods. The company incurred costs for testing, discounts on replacement orders, and inventory obsolescence. A settlement was reached with the supplier in Q3 2023, with recoveries recorded in 2024, mitigating some of these prior losses.

Industry Context

The food and beverage industry, particularly in the functional and health-focused segments, is highly competitive. Companies like Laird Superfood face challenges in differentiating their products, managing supply chain costs, and adapting to evolving consumer preferences for natural and sustainable ingredients. Innovation and effective marketing are crucial for capturing market share.

Regulatory Implications

While no specific new regulatory risks are detailed, companies in the food sector are subject to stringent food safety regulations (e.g., FDA). The past product quality issue highlights the importance of robust quality control and vendor management to avoid costly recalls and reputational damage.

What Investors Should Do

1. Monitor future equity financing activities.
2. Evaluate the impact of expiring NOLs.
3. Assess the resolution and financial impact of the product quality issue.

Key Dates

• 2023-01-01: Product Quality Issue Identified — Led to voluntary product withdrawal and associated costs, impacting operations and financials.
• 2023-09-30: Settlement with Supplier — Resolved the product quality issue with a vendor, leading to recoveries in the following year.
• 2024-01-01: Record of Recoveries — Mitigated some of the financial impact from the 2023 product quality issue.
• 2025-06-30: Common Stock Outstanding Reaches 11,020,792 — Indicates ongoing equity financing or stock-based compensation activity, potentially diluting existing shareholders.
• 2025-06-30: Additional Paid-In Capital Reaches $10,668,705 — Reflects continued capital raises or equity issuance, supporting company operations or growth initiatives.

Glossary

Common Stock Outstanding

The total number of shares of a company's common stock that are currently held by all its shareholders. (An increase in this metric, as seen from 10,644,461 to 11,020,792, can indicate dilution for existing shareholders due to new share issuances.)

Additional Paid-In Capital

The amount of money a company receives from selling stock above its par value. (An increase from $10,292,374 to $10,668,705 suggests the company has successfully raised capital through equity offerings.)

Net Operating Loss (NOL) Carryforwards

A tax provision that allows companies to use past operating losses to offset future taxable income, reducing their tax liability. (Laird Superfood has significant NOLs, with some expiring soon (2025) and others extending for many years, impacting its future tax strategy.)

Shares Withheld

Shares of common stock held back by the company, often to cover costs associated with stock options or tax liabilities from equity compensation. (The filing notes shares withheld for stock option exercise costs (8,772 in Q2 2025) and taxes (287,148 in 2024), indicating active equity compensation management.)

Year-Over-Year Comparison

The current filing shows an increase in common stock outstanding to 11,020,792 shares and additional paid-in capital to $10,668,705, indicating continued equity financing or stock-based compensation. This contrasts with the previous period's figures of 10,644,461 shares and $10,292,374 in capital, suggesting ongoing dilution and capital infusion. The company also continues to manage the aftermath of a product quality issue from early 2023, with recoveries noted in 2024, which would not have been a factor in prior periods.

Key Financial Figures

• $0.001 — e on which registered Common Stock, $0.001 par value LSF NYSE American Indic

Filing Documents

• lsf20250630_10q.htm (10-Q) — 1500KB
• ex_821589.htm (EX-31.1) — 13KB
• ex_821590.htm (EX-31.2) — 13KB
• ex_821591.htm (EX-32.1) — 5KB
• ex_821592.htm (EX-32.2) — 5KB
• logo.jpg (GRAPHIC) — 4KB
• 0001437749-25-025135.txt ( ) — 7774KB
• lsf-20250630.xsd (EX-101.SCH) — 68KB
• lsf-20250630_cal.xml (EX-101.CAL) — 52KB
• lsf-20250630_def.xml (EX-101.DEF) — 378KB
• lsf-20250630_lab.xml (EX-101.LAB) — 346KB
• lsf-20250630_pre.xml (EX-101.PRE) — 420KB
• lsf20250630_10q_htm.xml (XML) — 1650KB

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements 4 Unaudited Consolidated Condensed Balance Sheets 4 Unaudited Consolidated Condensed Statements of Operations 5 Unaudited Consolidated Condensed Statements of Stockholders ' Equity 6 Unaudited Consolidated Condensed Statements of Cash Flows 7 Notes to Unaudited Consolidated Condensed Financial Statements 8

Management ' s Discussion and Analysis of Financial Conditions and Results of Operations

Item 2. Management ' s Discussion and Analysis of Financial Conditions and Results of Operations 24

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 32

Controls and Procedures

Item 4. Controls and Procedures 33

Other Information

Part II. Other Information 34

Legal Proceedings

Item 1. Legal Proceedings 34

Risk Factors

Item 1A. Risk Factors 34

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 35

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 35

Other Information

Item 5. Other Information 35

Exhibits

Item 6. Exhibits 36

Signatures

Signatures 37 Laird, our logo and other trademarks or service marks appearing in this report are the property of Laird Superfood, Inc. Trade names, trademarks and service marks of other companies appearing in this report are the property of their respective owners. Solely for convenience, the trademarks, service marks and trade names included in this report are without the , or other applicable symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks and trade names. Unless the context otherwise indicates, references to "Laird Superfood," "we," "our," "us" and the "Company" refer to Laird Superfood, Inc. and its subsidiary on a consolidated basis. 2 Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements convey our current expectations or forecasts of future events and are not guarantees of future performance. Such forward-looking statements are based on numerous assumptions that we believe are reasonable, but they are open to a wide range of uncertainties and business risks. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Any statements contained in this Quarterly Report on Form 10-Q that are not statements of historical fact may be forward-looking statements. When we use the words "anticipates," "believes," "continues," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "seeks," "should," "will," "would," or the negative of these terms or other comparable terminology, we are identifying forward-looking statements. Forward-looking statements involve risks and uncertainties, which may cause our actual results, performance, or achiev

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements LAIRD SUPERFOOD, INC. CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) As of June 30, 2025 December 31, 2024 Assets Current assets Cash, cash equivalents, and restricted cash $ 4,184,775 $ 8,514,152 Accounts receivable, net 2,751,541 1,762,911 Inventory 11,027,615 5,975,676 Prepaid expenses and other current assets 1,253,258 1,713,889 Total current assets 19,217,189 17,966,628 Noncurrent assets Property and equipment, net 93,233 58,447 Intangible assets, net 816,078 896,123 Related party license agreements 132,100 132,100 Right-of-use assets 168,136 205,703 Total noncurrent assets 1,209,547 1,292,373 Total assets $ 20,426,736 $ 19,259,001 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 2,726,595 $ 2,137,760 Accrued expenses 4,066,255 3,642,998 Related party liabilities 57,947 34,947 Lease liabilities, current portion 107,555 105,966 Total current liabilities 6,958,352 5,921,671 Lease liabilities 94,443 140,464 Total liabilities 7,052,795 6,062,135 Stockholders' equity Common stock, $ 0.001 par value, 100,000,000 shares authorized at June 30, 2025 and December 31, 2024; 11,020,792 and 10,644,461 issued and outstanding at June 30, 2025, respectively; and 10,668,705 and 10,292,374 issued and outstanding at December 31, 2024, respectively. 10,644 10,292 Additional paid-in capital 121,999,967 121,304,884 Accumulated deficit ( 108,636,670 ) ( 108,118,310 ) Total stockholders' equity 13,373,941 13,196,866 Total liabilities and stockholders' equity $ 20,426,736 $ 19,259,001 The accompanying notes are an integral part of these unaudited consolidated condensed financial statements. 4 Table of Contents LAIRD SUPERFOOD, INC. CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited) Three Months Ended Six Months Ended June 30, June 30, 2025 2024 2025 2024 Sales, net $ 11,990,842 $ 10,003,654 $

View Full Filing

View this 10-Q filing on SEC EDGAR